Resources

Movember-funded study gives people with incurable prostate cancer more time

New research findings from a Movember-funded clinical trial called ENZA-p reveals a world-first combination treatment approach that has led to longer and better-quality lives for men living with incurable prostate cancer.

LuPSMA shows promise as first-line treatment for prostate cancer

A Peter MacCallum Cancer Centre study, part-funded by Movember, has led to a break-through in the treatment of early-stage prostate cancer.

Prostate cancer cases expected to double by 2040

Research by The Lancet says that annual prostate cancer cases and deaths are projected to rise.

Movember funds AI research to speed up personalised medicines for prostate cancer

Movember funding has supported ground-breaking new research which harnesses the use of artificial intelligence to improve prostate cancer treatment.

World-first prostate cancer trial shows new therapy is ‘safe and effective’

Movember funding has supported a world-first trial which has shown Lu-PSMA therapy is safe and effective for men with newly diagnosed localised prostate cancer.

Movember-funded testicular cancer project hits another milestone

The Movember-funded TIGER trial is a research project that looks at treating aggressive forms of testicular cancer. Find out about its latest milestone.

The Golidlocks Studies

A multi-phase study into when and how gaming supports mental health.

Mental fitness

What mental fitness actually is, why it matters, and the simple skills that help you build it.